MedPath

We are trying to see the effect of fentanyl and dexmedetomidine as an additive drug to levobupivacine in blocking the nerves in thoracic area present in paravertebral space in cases of modified breast surgery to see pain relief after operation.

Phase 4
Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2025/04/085646
Lead Sponsor
Dr Nafis Anwar
Brief Summary

We will compare the effect of fentanyl and dexmedetomidine as an adjuvant to levobupivacaine for post operative analgesia in paravertebral block in cases of modified radical mastectomy

Purpose of trial is to minimise the use of intravenous analgesic agent to prevent the incidence of post operative nausea and vomiting thus reducing the duration of hospital stay and patient morbidity

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
50
Inclusion Criteria

ASA grade I and II Modified radical mastectomy surgery requiring general anaesthesia Written and informed consent from patient BMI 20 to 25 kg/meter square.

Exclusion Criteria

Patient not giving consent Hypersensitivity to either study drug Patient having spinal deformity Infection at the site of block Patient having coagulopathy pregnancy and severe cardiopulmonary disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare time for first rescue analgesic requestTill 24 hrs from successful paravertebral block
Secondary Outcome Measures
NameTimeMethod
To compare Visual analogue scale score for pain & total analgesic consumptionTo compare side effects like Sedation nausea vomiting bradycardia & hypotension in the post operative period till 24 hours

Trial Locations

Locations (1)

Rajendra institute of medical sciences Ranchi Jharkhand India 834009

🇮🇳

Ranchi, JHARKHAND, India

Rajendra institute of medical sciences Ranchi Jharkhand India 834009
🇮🇳Ranchi, JHARKHAND, India
Dr Nafis Anwar
Principal investigator
7870929552
anwarnafis99@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.